HPV vaccination programmes should be extended to include young adult and adolescent men, researchers suggest.
Experts from the University of Texas say that the rise in throat and mouth cancers can be blamed on increasing numbers of human papillomavirus (HPV) infections among young men.
Cervical cancer-causing HPV strain 16 has been linked with cancers of the mouth and throat.
Researchers say this trend is particularly noticeable in men under the age of 45.
They add: "While the cervical cancer and dysplasia prevention policy of HPV16/8 vaccination of young women and adolescent females are commended, we fear that vaccination programmes limited to females will only delay the potential benefit in prevention of HPV16/18 associated oropharyngeal cancers, which typically occur in men."
The team want more studies to be conducted into the efficacy and safety of HPV vaccines in men.
If these are successful, they then will recommend the vaccination of young adult and adolescent males against HPV.